About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 809234, 8 pages
http://dx.doi.org/10.1155/2013/809234
Clinical Study

Effects of Water Extracts of Graptopetalum paraguayense on Blood Pressure, Fasting Glucose, and Lipid Profiles of Subjects with Metabolic Syndrome

1Department of Family and Community Medicine, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
2School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
3Center for Education and Research on Geriatrics and Gerontology, Chung Shan Medical University, Taichung 40201, Taiwan
4Department of Health Food, Chung Chou University of Science and Technology, Changhua 51003, Taiwan
5School of Nutrition, Chung Shan Medical University, Taichung 40201, Taiwan
6Department of Nutrition, Chung Shan Medical University Hospital, Taichung 40201, Taiwan

Received 16 September 2013; Accepted 29 October 2013

Academic Editor: Esteban Martinez

Copyright © 2013 Chi-Hua Yen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. I. Cleeman, “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” The Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Scopus
  2. E. Ferrannini, S. M. Haffner, B. D. Mitchell, and M. P. Stern, “Hyperinsulinaemia: the key feature of cardiovascular and metabolic syndrome,” Diabetologia, vol. 34, no. 6, pp. 416–422, 1991. View at Scopus
  3. E. S. Ford and W. H. Giles, “A comparison of the prevalence of the metabolic syndrome using two proposed definitions,” Diabetes Care, vol. 26, no. 3, pp. 575–581, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. Y.-W. Park, S. Zhu, L. Palaniappan, S. Heshka, M. R. Carnethon, and S. B. Heymsfield, “The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994,” Archives of Internal Medicine, vol. 163, no. 4, pp. 427–436, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. G. D. Kolovou, K. K. Anagnostopoulou, K. D. Salpea, and D. P. Mikhailidis, “The prevalence of metabolic syndrome in various populations,” The American Journal of the Medical Sciences, vol. 333, no. 6, pp. 362–371, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. C.-J. Yeh, H.-Y. Chang, and W.-H. Pan, “Time trend of obesity, the metabolic syndrome and related dietary pattern in Taiwan: from NAHSIT 1993-1996 to NAHSIT 2005-2008,” Asia Pacific Journal of Clinical Nutrition, vol. 20, no. 2, pp. 292–300, 2011. View at Scopus
  7. A. Ceriello, A. Quatraro, and D. Giugliano, “Diabetes mellitus and hypertension: the possible role of hyperglycaemia through oxidative stress,” Diabetologia, vol. 36, no. 3, pp. 265–266, 1993. View at Scopus
  8. D. Giugliano, A. Ceriello, and G. Paolisso, “Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress?” Metabolism, vol. 44, no. 3, pp. 363–368, 1995. View at Scopus
  9. I. C. West, “Radicals and oxidative stress in diabetes,” Diabetic Medicine, vol. 17, no. 3, pp. 171–180, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Antoniades, D. Tousoulis, C. Tentolouris, P. Toutouzas, and C. Stefanadis, “Oxidative stress, antioxidant vitamins, and atherosclerosis: from basic research to clinical practice,” Herz, vol. 28, no. 7, pp. 628–638, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Stocker and J. F. Keaney Jr., “Role of oxidative modifications in atherosclerosis,” Physiological Reviews, vol. 84, no. 4, pp. 1381–1478, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Penckofer, D. Schwertz, and K. Florczak, “Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants,” The Journal of Cardiovascular Nursing, vol. 16, no. 2, pp. 68–85, 2002. View at Scopus
  13. D. Giugliano, “Dietary antioxidants for cardiovascular prevention,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 10, no. 1, pp. 38–44, 2000. View at Scopus
  14. K.-F. Huang, Y.-W. Chen, C.-T. Chang, and S.-T. Chou, “Studies on the inhibitory effect of Graptopetalum paraguayense E. Walther extracts on mushroom tyrosinase,” Food Chemistry, vol. 89, no. 4, pp. 583–587, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. Y.-C. Chung, S.-J. Chen, C.-K. Hsu, C.-T. Chang, and S.-T. Chou, “Studies on the antioxidative activity of Graptopetalum paraguayense E. Walther,” Food Chemistry, vol. 91, no. 3, pp. 419–424, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. S.-J. Chen, C.-T. Chang, Y.-C. Chung, and S.-T. Chou, “Studies on the inhibitory effect of Graptopetalum paraguayense E. Walther extracts on the angiotensin converting enzyme,” Food Chemistry, vol. 100, no. 3, pp. 1032–1036, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. Y.-C. Chung, S.-J. Chen, H.-Y. Pengspi-Sup, and S.-T. Chou, “Anti hypertensive and antioxidant effects of the Graptopetalum paraguayense E. Walther extract in spontaneously hypertensive rats,” Journal of the Science of Food and Agriculture, vol. 89, no. 15, pp. 2678–2686, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S.-J. Chen, J.-G. Chung, Y.-C. Chung, and S.-T. Chou, “In vitro antioxidant and antiproliferative activity of the stem extracts from Graptopetalum paraguayense,” American Journal of Chinese Medicine, vol. 36, no. 2, pp. 369–383, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. P.-D. Duh, S.-L. Lin, and S.-C. Wu, “Hepatoprotection of Graptopetalum paraguayense E. Walther on CCl 4-induced liver damage and inflammation,” Journal of Ethnopharmacology, vol. 134, no. 2, pp. 379–385, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. L. J. Su, C. C. Chang, C. H. Yang, et al., “Graptopetalum paraguayense ameliorates chemical-induces rat hepatic fibrosis in vivo and inactivates stellate cells and kupffer cells in vitro,” PLoS ONE, no. 8, Article ID e53988, 2013.
  21. T.-K. Kao, Y.-C. Ou, S.-L. Raung et al., “Graptopetalum paraguayense E. Walther leaf extracts protect against brain injury in ischemic rats,” American Journal of Chinese Medicine, vol. 38, no. 3, pp. 495–516, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. L. Lin, H. Y. Peng, H. M. Hsieh, C. H. Lin, and S. T. Chou, “Effects of Graptopetalum paraguayense consumption on serum lipid profiles and antioxidative status in hypercholesteremic subjects,” Journal of the Science of Food and Agriculture, vol. 91, no. 7, pp. 1230–1235, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. K. G. M. M. Alberti and P. Zimmet, “The metabolic syndrome—a new worldwide definition,” The Lancet, vol. 366, no. 9491, pp. 1059–1062, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. S. M. Grundy, J. I. Cleeman, S. R. Daniels et al., “Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement,” Circulation, vol. 112, no. 17, pp. 2735–2752, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. Y.-C. Chung, S.-T. Chou, J.-K. Jhan, J.-W. Liao, and S.-J. Chen, “In vitro and in vivo safety of aqueous extracts of Graptopetalum paraguayense E. Walther,” Journal of Ethnopharmacology, vol. 140, no. 1, pp. 91–97, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. D. E. Paglia and W. N. Valentine, “Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase,” The Journal of Laboratory and Clinical Medicine, vol. 70, no. 1, pp. 158–169, 1967. View at Scopus
  27. S. Marklund and G. Marklund, “Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase,” European Journal of Biochemistry, vol. 47, no. 3, pp. 469–474, 1974. View at Scopus
  28. H. Aebi, “[13] Catalase in vitro,” Methods in Enzymology, vol. 105, no. C, pp. 121–126, 1984. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Karaouzene, H. Merzouk, M. Aribi et al., “Effects of the association of aging and obesity on lipids, lipoproteins and oxidative stress biomarkers: a comparison of older with young men,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 21, no. 10, pp. 792–799, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. S. A. B. E. Van Acker, D.-J. Van Den Berg, M. N. J. L. Tromp et al., “Structural aspects of antioxidant activity of flavonoids,” Free Radical Biology & Medicine, vol. 20, no. 3, pp. 331–342, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. W. Zheng and S. Y. Wang, “Antioxidant activity and phenolic compounds in selected herbs,” Journal of Agricultural and Food Chemistry, vol. 49, no. 11, pp. 5165–5170, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky, “Are oxidative stress—activated signaling pathways mediators of insulin resistance and β-cell dysfunction?” Diabetes, vol. 52, no. 1, pp. 1–8, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. J. I. Yang, M. H. Pan, M. L. Tsai, and W. C. Chen, “Effects of Shi-lan (Graptopetalum paraguayens) extracts on antioxidative performance and serum glucose level in Streptozotocin-induced diabetic rats,” Journal of National Kaohsiung Marine University, vol. 18, pp. 119–132, 2003 (Chinese).
  34. V. Poitout and R. P. Robertson, “Minireview: secondary β-cell failure in type 2 diabetes—a convergence of glucotoxicity and lipotoxicity,” Endocrinology, vol. 143, no. 2, pp. 339–342, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. M.-C. Blatter, R. W. James, S. Messner, F. Barja, and D. Pometta, “Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase,” European Journal of Biochemistry, vol. 211, no. 3, pp. 871–879, 1993. View at Publisher · View at Google Scholar · View at Scopus
  36. M. N. Rao, Q.-H. Liu, P. Marmillot, L. B. Seeff, D. B. Strader, and M. R. Lakshman, “High-density lipoproteins from human alcoholics exhibit impaired reverse cholesterol transport function,” Metabolism, vol. 49, no. 11, pp. 1406–1410, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Osaki, Y. Ikeda, T. Suehiro et al., “Roles of Sp1 and protein kinase C in regulation of human serum paraoxonase 1 (PON1) gene transcription in HepG2 cells,” Atherosclerosis, vol. 176, no. 2, pp. 279–287, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. C.-C. Cheng, L.-C. Wu, J.-M. Lai, C.-T. Chen, C.-M. Hsueh, and S.-L. Hsu, “Ethanol extract of Graptopetalum paraguayense upregulates paraoxonase 1 gene expression via an AKT/NF-κB-dependent pathway,” American Journal of Chinese Medicine, vol. 40, no. 2, pp. 357–372, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Mackness, P. Durrington, A. Povey et al., “Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep,” Pharmacogenetics, vol. 13, no. 2, pp. 81–88, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Papathanasopoulos and M. Camilleri, “Dietary fiber supplements: effects in obesity and metabolic syndrome and relationship to gastrointestinal functions,” Gastroenterology, vol. 138, no. 1, pp. 65–e2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. J. M. Assini, E. E. Mulvihill, and M. W. Huff, “Citrus flavonoids and lipid metabolism,” Current Opinion in Lipidology, vol. 24, no. 1, pp. 34–40, 2013.